LACOSAMIDE/TU - Search Results

Year	Number of Results
2016	1
2017	7
2018	43
2019	30
2020	42
2021	41
2022	32
2023	39
2024	46
2025	13

1

The adverse-effect profile of lacosamide.

Li J, Sun M, Wang X. Li J, et al. Expert Opin Drug Saf. 2020 Feb;19(2):131-138. doi: 10.1080/14740338.2020.1713089. Epub 2020 Jan 15. Expert Opin Drug Saf. 2020. PMID: 31914330 Review.

2

Lacosamide and pregnancy: Data from spontaneous and solicited reports.

Perucca P, Bourikas D, Voinescu PE, Vadlamudi L, Chellun D, Kumke T, Werhahn KJ, Schmitz B. Perucca P, et al. Epilepsia. 2024 May;65(5):1275-1284. doi: 10.1111/epi.17924. Epub 2024 Feb 27. Epilepsia. 2024. PMID: 38411300

3

[Paediatric status epilepticus].

Soto-Insuga V, González-Alguacil E, García-Peñas JJ. Soto-Insuga V, et al. Rev Neurol. 2022 Oct 16;75(8):225-238. doi: 10.33588/rn.7508.2022196. Rev Neurol. 2022. PMID: 36218253 Free PMC article. Review. Spanish.

4

Lacosamide: Associated Hyponatremia.

Gupta SS, Patti R, Lindsay D, Raheja H, Kupfer Y. Gupta SS, et al. Am J Ther. 2018 Nov/Dec;25(6):e729-e730. doi: 10.1097/MJT.0000000000000745. Am J Ther. 2018. PMID: 29975200 No abstract available.

5

Lacosamide add-on therapy for focal epilepsy.

Babar RK, Bresnahan R, Gillespie CS, Michael BD. Babar RK, et al. Cochrane Database Syst Rev. 2021 May 17;5(5):CD008841. doi: 10.1002/14651858.CD008841.pub3. Cochrane Database Syst Rev. 2021. PMID: 33998660 Free PMC article.

6

The cenobamate KORK study-A prospective monocenter observational study investigating cenobamate as an adjunctive therapy in refractory epilepsy, with comparisons to historical cohorts treated with add-on lacosamide, perampanel, and brivaracetam.

Steinhoff BJ, Georgiou D, Intravooth T. Steinhoff BJ, et al. Epilepsia Open. 2024 Aug;9(4):1502-1514. doi: 10.1002/epi4.12992. Epub 2024 Jun 11. Epilepsia Open. 2024. PMID: 38861254 Free PMC article.

7

Cardiac adverse events associated with lacosamide: a disproportionality analysis of the FAERS database.

Yang C, Zhao W, Chen H, Yao Y, Zhang J. Yang C, et al. Sci Rep. 2024 Jul 13;14(1):16202. doi: 10.1038/s41598-024-67209-0. Sci Rep. 2024. PMID: 39003359 Free PMC article.

8

Lacosamide-induced symptomatic sinus node dysfunction.

Minomo S, Amino T, Hara N, Ichijo M, Miyake T, Yasuura A, Kamata T. Minomo S, et al. Epileptic Disord. 2021 Oct 1;23(5):772-774. doi: 10.1684/epd.2021.1326. Epileptic Disord. 2021. PMID: 34583918 No abstract available.

9

Third-Generation Antiseizure Medications for Adjunctive Treatment of Focal-Onset Seizures in Adults: A Systematic Review and Network Meta-analysis.

Lattanzi S, Trinka E, Zaccara G, Striano P, Russo E, Del Giovane C, Silvestrini M, Brigo F. Lattanzi S, et al. Drugs. 2022 Feb;82(2):199-218. doi: 10.1007/s40265-021-01661-4. Epub 2022 Jan 21. Drugs. 2022. PMID: 35061214 Free PMC article.

10

Lacosamide serum concentrations during pregnancy.

Zutshi D, Millis SR, Basha MM, Daimee MA, Srinivas M. Zutshi D, et al. Epilepsy Behav. 2021 Oct;123:108253. doi: 10.1016/j.yebeh.2021.108253. Epub 2021 Aug 13. Epilepsy Behav. 2021. PMID: 34399392

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

256 results

Results by year